Skip to main content
Frontiers in Medicine logoLink to Frontiers in Medicine
. 2024 Jan 5;10:1337712. doi: 10.3389/fmed.2023.1337712

Corrigendum: Concurrent use of oral anticoagulants and sulfonylureas in individuals with type 2 diabetes and risk of hypoglycemia: a UK population-based cohort study

Hassan Alwafi 1,2, Ian C K Wong 1,3,4,5,6, Abdallah Y Naser 7, Amitava Banerjee 8,9,10, Pajaree Mongkhon 11,12, Cate Whittlesea 1, Alaa Alsharif 13, Li Wei 1,5,6,*
PMCID: PMC10797608  PMID: 38249973

In the published article, there was a mistake in the affiliation for “Alaa Alsharif.” The affiliation for “Alaa Alsharif” was displayed as “Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom.” The correct affiliation is “Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Medicine are provided here courtesy of Frontiers Media SA

RESOURCES